Evidence map›Paper›PMID 35323014›Full record

ArticleAntimicrobial agents and chemotherapy2022

Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant

Mark S Butler, Valeria Gigante, Hatim Sati, Sarah Paulin, Laila Al-Sulaiman, John H Rex, Prabhavathi Fernandes, Cesar A Arias, Mical Paul, Guy E Thwaites and 9 more

Abstract readLetterComment
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Mark S ButlerMSBChem Consulting, Brisbane, Queensland, Australia.ORCID 0000-0001-6689-4236
Valeria GiganteAntimicrobial Resistance Division, WHO, Geneva, Switzerland.
Hatim SatiAntimicrobial Resistance Division, WHO, Geneva, Switzerland.
Sarah PaulinAntimicrobial Resistance Division, WHO, Geneva, Switzerland.
Laila Al-SulaimanAntimicrobial Resistance Division, WHO, Geneva, Switzerland.
John H RexF2G Limited, Eccles, Cheshire, United Kingdom.
Prabhavathi FernandesScientific Advisory Committee, GARDP, Geneva, Switzerland.
Cesar A AriasCenter for Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, USA.
Mical PaulInfectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel.
Guy E ThwaitesOxford University Clinical Research Unitgrid. 412433.3, Ho Chi Minh City, Vietnam.
Lloyd CzaplewskiChemical Biology Ventures Ltd, Abingdon, Oxfordshire, United Kingdom.
Richard A AlmCARB-X, Boston University, Boston, Massachusetts, USA.ORCID 0000-0002-5056-7377
Christian LienhardtUniversité de Montpellier, Institut de Recherche pour le Développement, INSERM, Montpellier, France.
Melvin SpigelmanTB Alliance, New York, New York, USA.
Lynn L SilverLL Silver Consulting, Springfield, New Jersey, USA.
Norio OhmagariNational Center for Global Health and Medicine, Shinjuku City, Tokyo, Japan.
Roman KozlovInstitute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia.
Stephan HarbarthNational Center for Infection Prevention, Swissnoso, Bern, Switzerland.
Peter BeyerAntimicrobial Resistance Division, WHO, Geneva, Switzerland.

Funding

Project 3: Functional Microbiome and Host Signatures in Transition from Commensal to pathogenP01AI152999 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SAVIDGE, TOR C. · 2020 to 2025
$12.0M
VENOUS: A translational study of enterococcal bacteremiaR01AI148342 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2020 to 2024
$3.9M
POR Program on Genomic Prediction of Antimicrobial Resistance in VREK24AI121296 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2016 to 2025
$1.5M
NIAID NIH HHS K24 AI121296NIAID NIH HHS P01 AI152999NIAID NIH HHS R01 AI148342World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35323014
PMCPMC9017292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.